Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cp-868,596
1. 670220-88-9
2. Crenolanib (cp-868596)
3. Cp-868596
4. Aro-002
5. Crenolanib [usan]
6. Cp-868,596
7. Aro 002
8. Cp 868596
9. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
10. Lqf7i567tq
11. Cp868569
12. Crenolanib (usan)
13. Mfcd21609260
14. 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
15. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine
16. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine
17. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.
18. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine
19. Cp-868
20. Cp868596
21. Crenolanib [usan:inn]
22. Unii-lqf7i567tq
23. Crenolanibum
24. Cp-868596 (crenolanib)
25. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzimidazol-1-yl)quinolin-8-yl)piperidin-4-amine
26. 6t2
27. Cp-868569
28. Crenolanib [inn]
29. Crenolanib,cp-868596
30. [1-[2-[5-(3-methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine
31. Crenolanib [who-dd]
32. Mls006010956
33. Crenolanib - Cp-868569
34. Gtpl7882
35. Schembl2730601
36. Chembl2105728
37. Dtxsid50985873
38. Ex-a215
39. Chebi:145365
40. Bdbm185149
41. Hms3656f19
42. Bcp02384
43. Zinc3820043
44. Nsc763526
45. Nsc800079
46. S2730
47. Akos026750597
48. Bcp9000551
49. Ccg-264988
50. Cs-0566
51. Db11832
52. Nsc-763526
53. Nsc-800079
54. Sb16603
55. Ncgc00346658-01
56. Ncgc00346658-09
57. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
58. Ac-32071
59. As-57698
60. Hy-13223
61. Smr004702760
62. Sy237889
63. Ft-0665221
64. Sw218293-2
65. D10102
66. J-502712
67. Q5184160
68. Cp-868596;cp 868596;cp868596;aro 002
69. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1h-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine
70. 1-{2-[5-(3-methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine
71. 4-piperidinamine, 1-(2-(5-((3-methyl-3-oxetanyl)methoxy)-1h-benzimidazol-1-yl)-8-quinolinyl)-
| Molecular Weight | 443.5 g/mol |
|---|---|
| Molecular Formula | C26H29N5O2 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 443.23212518 g/mol |
| Monoisotopic Mass | 443.23212518 g/mol |
| Topological Polar Surface Area | 78.4 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 667 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Crenolanib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crenolanib, including repackagers and relabelers. The FDA regulates Crenolanib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crenolanib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Crenolanib supplier is an individual or a company that provides Crenolanib active pharmaceutical ingredient (API) or Crenolanib finished formulations upon request. The Crenolanib suppliers may include Crenolanib API manufacturers, exporters, distributors and traders.
Crenolanib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Crenolanib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Crenolanib GMP manufacturer or Crenolanib GMP API supplier for your needs.
A Crenolanib CoA (Certificate of Analysis) is a formal document that attests to Crenolanib's compliance with Crenolanib specifications and serves as a tool for batch-level quality control.
Crenolanib CoA mostly includes findings from lab analyses of a specific batch. For each Crenolanib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Crenolanib may be tested according to a variety of international standards, such as European Pharmacopoeia (Crenolanib EP), Crenolanib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crenolanib USP).
LOOKING FOR A SUPPLIER?
